Placebo to MK-0616
Sponsors
Merck Sharp & Dohme LLC
Conditions
Elevated lipoprotein(a)Heterozygous Familial Hypercholesterolemia in pediatric patients
Phase 2
An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants with Heterozygous Familial Hypercholesterolemia
Not yet recruitingCTIS2024-519068-42-00
Target: 10Updated: 2026-01-27
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-7262 as Monotherapy and when Coadministered with Enlicitide Decanoate in Adults With Elevated Lipoprotein(a)
Not yet recruitingCTIS2025-525102-38-00
Target: 125Updated: 2026-08-18